Sponsor Pipeline

EpiBiologics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07462377 A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC Epidermal Growth Factor Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Head & Neck Cancer (1)
Get alerts when EpiBiologics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free